Rsp-Ravi Specialities Pharma (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2018
- Satisfied Charges ₹ 6.00 M
as on 05-12-2024
About Rsp-Ravi Specialities Pharma (Opc)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹6.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Thangavel Ranjith serves as a director at the Company.
- CIN/LLPIN
U74999TN2017OPC116110
- Company No.
116110
- Incorporation Date
18 Apr 2017
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruchirappalli, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rsp-Ravi Specialities Pharma (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thangavel Ranjith  | Director | 18-Apr-2017 | Current |
Financial Performance of Rsp-Ravi Specialities Pharma (Opc).
Rsp-Ravi Specialities Pharma (Opc) Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rsp-Ravi Specialities Pharma (Opc)?
In 2018, Rsp-Ravi Specialities Pharma (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Trichy-Ravi Remedy Drugs Private LimitedActive 7 years 3 monthsThangavel Ranjith is a mutual person
Imphal-Ravispecialitiespharma Private LimitedActive 6 years 11 monthsThangavel Ranjith is a mutual person
- Trichy-Ravi Speed Parcel Services Private LimitedActive 7 years 1 month
Thangavel Ranjith is a mutual person
- Trichy-Ravi Consumer Care Private LimitedActive 7 years 3 months
Thangavel Ranjith is a mutual person
- Ravi Worldwide Medicines Private LimitedActive 7 years 2 months
Thangavel Ranjith is a mutual person
Charges (Loans)
₹0
₹6.00 M
Charges Breakdown by Lending Institutions
- Tamilnad Mercantile Bank Limited : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Aug 2018 | Tamilnad Mercantile Bank Limited | ₹6.00 M | Satisfied |
How Many Employees Work at Rsp-Ravi Specialities Pharma (Opc)?
Unlock and access historical data on people associated with Rsp-Ravi Specialities Pharma (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rsp-Ravi Specialities Pharma (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rsp-Ravi Specialities Pharma (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.